title: Basilar artery disease--clinical outcome and Doppler sonographical follow-up.
abstract: In the past 5 years we have investigated 29 patients with symptomatic basilar artery stenoses (14 cases) and occlusions (14) and a patent primitive trigeminal artery with thin-calibered basilar and vertebral arteries (1) using directional continuous-wave Doppler sonography of the vertebral arteries. A total of 19 patients survived, and 17 of them were clinically and sonographically reexamined after 40.4 +/- 15.8 months (mean +/- SD). Among the 8 patients with basilar stenoses, 6--with no further transient ischemic attacks (TIAs) in the interval--exhibited an increase in the summed modified Pourcelot indices (relative end-diastolic flow velocities) of the vertebrals by 0.18 +/- 0.16; the other 2 showed a decrease by 0.26 each, in 1 case temporally related to a TIA, in the 2nd case without further clinical deterioration. In the 8 survivors with basilar occlusions, 5 remained--by sonographic criteria--unchanged with summed modified Pourcelot indices of the vertebrals of 0.00, while 3 patients exhibited a slight increase in the summed modified Pourcelot indices of 0.13 +/- 0.03. While the difference between the outcome of subsets of patients treated with regimens of 30,000-40,000 units heparin/day or phenprocoumon and less radical drugs were statistically not significant, the former regimen appeared clinically more efficacious in preventing further deterioration in approximately two-thirds of the patients affected. Due to the potential recurrence of neurological symptoms, a treatment period with phenprocoumon of 6 months after discharge from hospital appears justified. Due to these therapeutic efforts, approximately half of the patients initially affected survived with no or only a mild neurological deficit.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Zentralinstitut für Seelische Gesundheit, Mannheim, Federal Republic of Germany.
authors.forename: S
authors.initials: S
authors.lastname: Biedert
authors.forename: U
authors.initials: U
authors.lastname: Schulz
authors.forename: H
authors.initials: H
authors.lastname: Betz
authors.forename: R
authors.initials: R
authors.lastname: Reuther
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001488:Basilar Artery / Q000473:pathology; D001925:Brain Damage, Chronic / Q000473:pathology; D002544:Cerebral Infarction / Q000473:pathology; D003251:Constriction, Pathologic / Q000473:pathology; D004453:Echoencephalography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002546:Ischemic Attack, Transient / Q000473:pathology; D008297:Male; D008875:Middle Aged; D014463:Ultrasonography; D014715:Vertebrobasilar Insufficiency / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000925:Anticoagulants